Anna P. Matynia
No Rating Available
(Learn About Our Rating System)

Anna P. Matynia, MD

Languages spoken: English, Polish

  • Dr. Matynia is the Head of Clinical Operations for Solid Tumor Molecular Pathology at ARUP. She is also an associate professor at the University of Utah.

    Specialties

    • Pathology, Clinical
    • Hematopathology
    • Pathology, Anatomical

    Board Certification

    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Hematology)
    American Board of Pathology (Sub: Molecular Genetic Pathology)

  • Dr. Matynia is the Head of Clinical Operations for Solid Tumor Molecular Pathology at ARUP. She is also an associate professor at the University of Utah.

    Board Certification and Academic Information

    Academic Departments Pathology -Associate Professor (Clinical)
    Board Certification
    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Hematology)
    American Board of Pathology (Sub: Molecular Genetic Pathology)

    Education history

    Fellowship Molecular Genetic Pathology - University of Utah/ARUP Laboratories Fellow
    Fellowship Hematopathology - University of Utah/ARUP Laboratories Fellow
    Chief Resident Anatomic and Clinical Pathology - University of Utah/ARUP Laboratories Co-Chief Resident
    Residency Anatomic and Clinical Pathology - University of Utah/ARUP Laboratories Resident
    Internship University Hospital Transitional Internship
    Professional Medical Medicine - Jagiellonian University M.D.

    Selected Publications

    Journal Article

    1. Li P, Alnoor FNU, Xie W, Williams M, Feusier J, Ding Y, Zhao X, Zheng G, Zhao C, Zieske AW, Zu Y, Raess PW, Tantravahi S, Osman A, Patel AB, Tashi T, Patel JL, Matynia AP, Menon MP, Miles RR, Jacobsen JR, George TI, Sborov DW, Szankasi P, Rindler P, Close D, Ohgami RS (2024). Rapid growth of acquired UBA1 mutations predisposes male patients to low-risk MDS. Leukemia, 39(1), 248-256. (Read full article)
    2. Wilcock DM, Schmidt RL, Furtado LV, Matynia AP, Deftereos G, Sirohi D (2021). Histologic and Molecular Characterization of Non-Small Cell Lung Carcinoma With Discordant ROS1 Immunohistochemistry and Fluorescence In Situ Hybridization. Appl Immunohistochem Mol Morphol, 30(1), 19-26. (Read full article)
    3. Stewart RL, Matynia AP, Factor RE, Varley KE (2020). Spatially-resolved quantification of proteins in triple negative breast cancers reveals differences in the immune microenvironment associated with prognosis. Sci Rep, 10(1), 6598. (Read full article)
    4. Deftereos G, Sandoval A, Furtado LV, Bronner M, Matynia AP (2020). Successful lung cancer EGFR sequencing from DNA extracted from TTF-1 immunohistochemistry slides: a new means to extend insufficient tissue. Hum Pathol, 97, 52-59. (Read full article)
    5. Matynia AP, Li KD, Szankasi P, Schumacher J, Liew M, Salama ME, Kelley TW (2018). Molecular Fingerprinting of Anatomically and Temporally Distinct B-Cell Lymphoma Samples by Next-Generation Sequencing to Establish Clonal Relatedness. Arch Pathol Lab Med, 143(1), 105-111. (Read full article)
    6. Matynia AP, Perkins SL, Li D (2018). Lymphomatoid Granulomatosis in a 14-Year-Old Boy with Trisomy 21 and History of B-Lymphoblastic Leukemia/Lymphoma. Fetal Pediatr Pathol, 37(1), 7-14. (Read full article)
    7. Schumacher JA, Scott Reading N, Szankasi P, Matynia AP, Kelley TW (2015). A novel approach to quantitating leukemia fusion transcripts by qRT-PCR without the need for standard curves. Exp Mol Pathol, 99(1), 104-8. (Read full article)

    Case Report

    1. Jedrzkiewicz J, Quencer K, Matynia AP, Morrow E, Pletneva M, Barraza G (2019). Peutz-Jeghers Type Polyp of the Appendix with Review of Literature. Case Rep Pathol, 2019, 7584070. (Read full article)